Rezafungin is a novel, long-acting echinocandin antifungal agent indicated for the intravenous treatment of candidemia and invasive candidiasis. By inhibiting the 1,3-β-D-glucan synthase enzyme complex,… Read more
Rezafungin is a novel, long-acting echinocandin antifungal agent indicated for the intravenous treatment of candidemia and invasive candidiasis. By inhibiting the 1,3-β-D-glucan synthase enzyme complex, this drug disrupts the formation of a critical component of the fungal cell wall, providing a targeted approach to managing systemic fungal infections. Laboratories rely on high-quality reference standards of the Rezafungin active pharmaceutical ingredient to support comprehensive analytical testing and method validation. Furthermore, the availability of characterized impurities and metabolites is essential for conducting impurity profiling and ensuring rigorous quality control throughout the drug development lifecycle. Stable isotope-labelled compounds for Rezafungin are also vital tools, serving as internal standards in complex bioanalytical assays to provide accurate quantification and trace analysis. These specialized materials facilitate compliance with regulatory expectations and support the precise characterization of drug substances and related degradation products.